Showing 730 – 740 of 1158 results
-
P3 Health Partners Inc
William Blair initiated research coverage of P3 Health Partners Inc. (PIII $6.49), a physician-led and technology-enabled advanced primary care partner, working with independent provider groups to enable their transformation to risk-based payment models.
-
General Dynamics Corporation Initiation
William Blair initiated research coverage of General Dynamics Corporation (GD $225.50).
-
Kura Sushi USA, Inc. Initiation
William Blair initiated research coverage of Kura Sushi USA, Inc. (KRUS $48.62). Kura Sushi is a revolving sushi bar with over 130 small plates alongside a full menu available via tableside ordering panels.
-
Applied Therapeutics Inc Initiation
William Blair initiated research coverage of Applied Therapeutics, Inc. (APLT $5.04), a development-stage biotechnology company with a pipeline that includes late-stage assets in several rare diseases and some opportunities in larger indications.
-
Signify Health Inc Initiation
William Blair & Company initiated research coverage of Signify Health, Inc. (SGFY $27.74). Signify Health, based in Dallas, Texas, is a technology-enabled healthcare platform that powers value-based payments programs through in-home health evaluations in its Home and Community Services (HCS) business, and manages episode-based payment program spend in its Episodes of Care Services (ECS) business.
-
Agilysys, Inc.: Initiation of Research Coverage
William Blair initiated research coverage of Agilysys, Inc. (AGYS $94.81), a comprehensive software provider for the broader hospitality industry.
-
Nasdaq Inc Initiation
William Blair initiated research coverage of Nasdaq, Inc. (NDAQ $80.88), a leading global technology company with a broad range of offerings, including equities and options exchanges, data, investment analytics, software, marketplace technology, and corporate solutions.
-
Chinook Therapeutics Inc Initiation
William Blair & Company initiated research coverage of Chinook Therapeutics, Inc. (KDNY). Following the completion of the merger with Aduro Biotech, Chinook is a leading biotech company focused on the treatment of rare, severe chronic kidney diseases.
-
Neurogene Inc. Initiation
William Blair initiated research coverage of Neurogene Inc. (NGNE $45.06), a genetic medicine company focused on the development of AAV-based therapies for the treatment of rare neurological diseases.
-
Bentley Systems Incorporated Initiation
William Blair initiated research coverage of Bentley Systems, Incorporated (BSY $51.19), a leading provider of design, build, operate, and maintain software for the infrastructure industry.